Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the displayed study information.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2. This appears to be a minor metadata/UI update with no change to study information.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.4.2 is now shown on the page, replacing Revision: v3.4.1. This appears to be a minor behind-the-scenes update with no user-facing content changes.SummaryDifference0.1%

- Check89 days agoChange DetectedMinor site revision updated from v3.4.0 to v3.4.1; no changes to study content or critical information, and the layout remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.